We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
GlaxoSmithKline (GSK) reported revenue of approximately $42.97 billion in 2006, up 9 percent from the year before, riding strong performances by Avandia, Lamictal and its vaccines.